Cubist Systematic Strategies’s Microbot Medical MBOT Stock Holding History

Cubist Systematic Strategies’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$119K	Buy	+38,985	New	+$122K	﹤0.01%	2752

Other funds holding MBOT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cubist Systematic Strategies's MBOT Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Microbot Medical (MBOT) in Q3 2025: 38,985 shares worth $119K. The stake represents ﹤0.01% of the portfolio and ranks #2752 among its holdings.

67 funds tracked by Wall St. Rank hold MBOT as of Q3 2025.

Cubist Systematic Strategies held 38,985 shares of Microbot Medical worth $119K as of Q3 2025.
Microbot Medical was a new Cubist Systematic Strategies position in Q3 2025.
Microbot Medical made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2752 holding.
67 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.